Share on StockTwits

Hyperion Therapeutics (NASDAQ:HPTX) released its earnings data on Thursday. The company reported $0.81 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.03) by $0.84, Stock Ratings Network.com reports. The company had revenue of $37.10 million for the quarter, compared to the consensus estimate of $22.00 million. During the same quarter last year, the company posted $1.17 earnings per share. Hyperion Therapeutics’s revenue was up 408.2% compared to the same quarter last year.

Hyperion Therapeutics (NASDAQ:HPTX) traded down 0.96% on Thursday, hitting $21.96. The stock had a trading volume of 76,950 shares. Hyperion Therapeutics has a 52-week low of $18.97 and a 52-week high of $32.98. The stock has a 50-day moving average of $24.48 and a 200-day moving average of $26.20. The company has a market cap of $445.0 million and a P/E ratio of 17.94.

Hyperion Therapeutics, Inc (NASDAQ:HPTX)is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.